Evidence for genetic linkage of Alzheimer's disease to chromosome 10q - PubMed (original) (raw)

. 2000 Dec 22;290(5500):2302-3.

doi: 10.1126/science.290.5500.2302.

D Blacker, K Mullin, D Keeney, J Jones, S Basu, S Yhu, M G McInnis, R C Go, K Vekrellis, D J Selkoe, A J Saunders, R E Tanzi

Affiliations

• PMID: 11125142
• DOI: 10.1126/science.290.5500.2302

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q

L Bertram et al. Science. 2000.

Abstract

Recent studies suggest that insulin-degrading enzyme (IDE) in neurons and microglia degrades Abeta, the principal component of beta-amyloid and one of the neuropathological hallmarks of Alzheimer's disease (AD). We performed parametric and nonparametric linkage analyses of seven genetic markers on chromosome 10q, six of which map near the IDE gene, in 435 multiplex AD families. These analyses revealed significant evidence of linkage for adjacent markers (D10S1671, D10S583, D10S1710, and D10S566), which was most pronounced in late-onset families. Furthermore, we found evidence for allele-specific association between the putative disease locus and marker D10S583, which has recently been located within 195 kilobases of the IDE gene.

PubMed Disclaimer

Similar articles

• Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
  Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; Japanese Genetic Study Consortium for Alzeheimer's Disease. Kuwano R, et al. Hum Mol Genet. 2006 Jul 1;15(13):2170-82. doi: 10.1093/hmg/ddl142. Epub 2006 Jun 1. Hum Mol Genet. 2006. PMID: 16740596
• Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
  Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA. Blomqvist ME, et al. Neurobiol Aging. 2005 Jun;26(6):795-802. doi: 10.1016/j.neurobiolaging.2004.07.011. Neurobiol Aging. 2005. PMID: 15718037 Clinical Trial.
• No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
  Sakai A, Ujike H, Nakata K, Takehisa Y, Imamura T, Uchida N, Kanzaki A, Yamamoto M, Fujisawa Y, Okumura K, Kuroda S. Sakai A, et al. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):87-91. doi: 10.1002/ajmg.b.20106. Am J Med Genet B Neuropsychiatr Genet. 2004. PMID: 14755451
• [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
  Panza F, Solfrizzi V, D'Introno A, Capurso C, Colacicco AM, Torres F, Altomare E, Capurso A. Panza F, et al. Recenti Prog Med. 2002 Sep;93(9):489-97. Recenti Prog Med. 2002. PMID: 12355988 Review. Italian.
• Molecular genetics of late-onset Alzheimer's disease.
  Kamboh MI. Kamboh MI. Ann Hum Genet. 2004 Jul;68(Pt 4):381-404. doi: 10.1046/j.1529-8817.2004.00110.x. Ann Hum Genet. 2004. PMID: 15225164 Review.

Cited by

• Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
  Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ. Farris W, et al. Am J Pathol. 2004 Apr;164(4):1425-34. doi: 10.1016/s0002-9440(10)63229-4. Am J Pathol. 2004. PMID: 15039230 Free PMC article.
• Protein aggregates and dementia: is there a common toxicity?
  Lovestone S, McLoughlin DM. Lovestone S, et al. J Neurol Neurosurg Psychiatry. 2002 Feb;72(2):152-61. doi: 10.1136/jnnp.72.2.152. J Neurol Neurosurg Psychiatry. 2002. PMID: 11796764 Free PMC article. Review.
• Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman.
  Selkoe DJ. Selkoe DJ. Neurochem Res. 2003 Nov;28(11):1705-13. doi: 10.1023/a:1026065122854. Neurochem Res. 2003. PMID: 14584824 Review.
• Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?
  Bertram L, Mullin K, Parkinson M, Hsiao M, Moscarillo TJ, Wagner SL, Becker KD, Velicelebi G, Blacker D, Tanzi RE. Bertram L, et al. J Med Genet. 2007 Jan;44(1):e63. doi: 10.1136/jmg.2005.039263. J Med Genet. 2007. PMID: 17209133 Free PMC article.
• Mechanisms of Abeta clearance and catabolism.
  Guénette SY. Guénette SY. Neuromolecular Med. 2003;4(3):147-60. doi: 10.1385/NMM:4:3:147. Neuromolecular Med. 2003. PMID: 14716023 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information